List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 252 studies with search of:   "Busulfan"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Double Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Neuroblastoma;   Immunodeficiencies;   Anemia
Interventions: Drug: TBI, Thiotepa, Cyclophosphamide, ATG;   Drug: Busulfan, Melphalan, Rabbit ATG;   Drug: Busulfan, Fludarabine, Alemtuzumab;   Drug: Busulfan, Fludarabine, Rabbit ATG;   Drug: Fludarabine, Cyclophosphamide, ATG;   Drug: Busulfan, Cyclosphosphamide, Rabbit ATG,
2 Active, not recruiting Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Conditions: Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Allogeneic Marrow Transplant
Interventions: Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
3 Recruiting Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
Condition: Leukemia
Interventions: Drug: Imatinib Mesylate;   Drug: Fludarabine;   Drug: Busulfan;   Drug: ATG
4 Recruiting Busulfan and Fludarabine Followed by Post-Transplant Cyclophosphamide
Conditions: Hematologic Diseases;   Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide
5 Recruiting Autologous and Allogeneic Transplant for Relapsed Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Hodgkins Disease
Interventions: Drug: Fludarabine and Busulfan;   Drug: Fludarabine, Busulfan and ATG
6 Recruiting Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for AML and MDS
Conditions: Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Thymoglobulin;   Drug: Busulfan;   Drug: Fludarabine
7 Recruiting Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
Conditions: Multiple Myeloma;   Lymphoma
Interventions: Drug: Busulfan;   Drug: Melphalan
8 Recruiting Allogeneic Stem Cell Transplantation for Myelofibrosis
Condition: Myelofibrosis
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Thymoglobulin (ATG)
9 Completed Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
Conditions: Chronic Myeloid Leukemia;   Acute Myelogenous Leukemia;   Myelodysplasia;   Acute Lymphocytic Leukemia;   Severe Aplastic Anemia;   Non-Hodgkin's Lymphoma;   Lymphoproliferative Disease;   Multiple Myeloma;   Advanced Myeloproliferative Disease
Intervention: Drug: Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF
10 Recruiting Phase II Trial of Pentostatin and Targeted Busulfan
Condition: Hematologic Malignancies
Intervention: Drug: Pentostatin/busulfan/rituximab/allogeneic hematopoietic cell transplant
11 Recruiting Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
Conditions: Myelodysplastic Syndromes;   Myeloproliferative Disorders;   Leukemia, Lymphocytic;   Myeloma;   Lymphoma
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Procedure: Bone Marrow Transplantation
12 Recruiting Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
Conditions: AML;   MDS;   ALL;   CML;   Lymphoma
Intervention: Drug: fludarabine phosphate, busulfan
13 Recruiting Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population
Condition: Signs and Symptoms, Respiratory
Interventions: Drug: busulfan;   Procedure: respiratory function tests, before allograft or autograft and at several times in the follow up (3, 6, 12, 18 and 24 months).;   Procedure: pharmacokinetics, done during the treatment
14 Recruiting Allogeneic Transplantation With Dose-Adjusted Busulfan
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndromes;   Agnogenic Myeloid Metaplasia
Intervention: Drug: Busulfan
15 Recruiting Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Transplantation;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: ATG (Thymoglobulin);   Drug: Azacitidine (Vidaza);   Procedure: Stem Cell Transplant;   Drug: Tacrolimus;   Drug: Methotrexate
16 Recruiting Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Conditions: MDS;   Leukemias;   Lymphomas
Intervention: Drug: Drug: busulfan, Cyclophosphamide, Total Body Irradiation
17 Active, not recruiting Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation
Condition: Acute Myeloid Leukemia (AML)
Interventions: Drug: G-CSF;   Drug: Leukapheresis;   Drug: Busulfan;   Procedure: Stem cell reinfusion
18 Recruiting Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Busulfan;   Drug: Fludarabine
19 Active, not recruiting Busulfan and Fludarabine in Patients With AML and MDS
Condition: Leukemia
Interventions: Drug: Busulfan;   Drug: Fludarabine
20 Recruiting Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Conditions: Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Gemcitabine;   Drug: Melphalan;   Other: Hematopoietic Cell Transplantation;   Drug: Rituximab for Patients with B-Cell Malignancies

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services